Koyfin Home > Directory > Health Care > Antares Pharma > Issuance of Common Stock

Antares Pharma Issuance of Common Stock Chart (ATRS)

Antares Pharma annual/quarterly Issuance of Common Stock from 2001 to 2018.
  • Antares Pharma Issuance of Common Stock for the quarter ending September 09, 2018 was $0m a -94.47% decrease of 0m year over year
  • Antares Pharma Issuance of Common Stock for the last 12 months ending September 09, 2018 was $1m a -254.69% decrease of -1m year over year
  • Antares Pharma Annual Issuance of Common Stock for 2017 was $2m a 94.44% increase of 2m from 2016
  • Antares Pharma Annual Issuance of Common Stock for 2016 was $0m a -42,357.43% decrease of -43m from 2015
  • Antares Pharma Annual Issuance of Common Stock for 2015 was $43m a 92.76% increase of 40m from 2014
Other Cash Flow Metrics:
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Issuance of Common Stock Data

09/2018$0m
06/2018$0m
03/2018$0m
12/2017$0m
09/2017$0m
06/2017$1m
03/2017$0m
12/2016$0m
09/2016$0m
12/2015$0m

Annual ATRS Issuance of Common Stock Data

2017$2m
2016$0m
2015$43m
2014$3m
2013$2m
2012$65m
2011$27m
2010$2m
2009$11m
2008$1m